- Home
- / Nightstar Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Nightstar Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
CreditSafe Score
?
Score changed on Jun 12, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|
| General and administrative expense | 2.1M | 2.1M | 7.0M | 12.6M |
| Operating expense total | 9.3M | 12.2M | 27.5M | 44.2M |
| EBIT | (9.3M) | (12.2M) | ||
| Interest income | 9.0K | 22.0K | 709.0K | 2.9M |
| Interest expense | 2.1M | 6.9M | ||
| Pre tax profit | (29.6M) | (37.3M) | ||
| Income tax expense | 37.0K | (440.0K) | ||
| Net Income | (13.6M) | (12.2M) | (29.7M) | (36.9M) |